Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9375 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.9219 |
High Similarity |
NPD4908 |
Phase 1 |
0.912 |
High Similarity |
NPD1610 |
Phase 2 |
0.8712 |
High Similarity |
NPD4625 |
Phase 3 |
0.8702 |
High Similarity |
NPD2861 |
Phase 2 |
0.8651 |
High Similarity |
NPD1548 |
Phase 1 |
0.8538 |
High Similarity |
NPD4749 |
Approved |
0.8519 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD1613 |
Approved |
0.8507 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8358 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8321 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8162 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8042 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7971 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7945 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7887 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7877 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7846 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7836 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7832 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7832 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7817 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7817 |
Intermediate Similarity |
NPD4538 |
Approved |
0.781 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7794 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7748 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7655 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7655 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7655 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7639 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7597 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.758 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7559 |
Intermediate Similarity |
NPD968 |
Approved |
0.7552 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD37 |
Approved |
0.752 |
Intermediate Similarity |
NPD846 |
Approved |
0.752 |
Intermediate Similarity |
NPD940 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7464 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7464 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7452 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7444 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7431 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD6666 |
Approved |
0.74 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7385 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7379 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7364 |
Intermediate Similarity |
NPD290 |
Approved |
0.7362 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1240 |
Approved |
0.736 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7312 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7293 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7293 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3846 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2801 |
Approved |
0.726 |
Intermediate Similarity |
NPD1607 |
Approved |
0.726 |
Intermediate Similarity |
NPD2157 |
Approved |
0.7248 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1511 |
Approved |
0.723 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7030 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7174 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7174 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7163 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7133 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD5451 |
Approved |
0.712 |
Intermediate Similarity |
NPD2859 |
Approved |
0.712 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7097 |
Intermediate Similarity |
NPD920 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7119 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7092
|
Intermediate Similarity |
NPD3685 |
Discontinued |